Neoadjuvant Anti-PD-L1/Chemo Combo Shows Promise in Resectable NSCLC

(MedPage Today) -- Study Authors: Catherine A. Shu, Justin F. Gainor, et al.; Rafael Rosell, Masaoki ItoTarget Audience and Goal Statement: Oncologists, pulmonologistsThe goal of this study was to determine the benefit/risk profile of neoadjuvant...